An abnormal von Willebrand factor (vWF) gene restriction pattern has been found in a patient with von Willebrand disease. Because this gene alteration is not present in his parents or in 50 normal and 25 affected subjects, and the restriction fragment length polymorphism haplotypes are inherited normally in the patient's family, we suggest that a de novo mutation is present. Bands with reduced intensity and additional fragments, observed in several restriction digests, hybridize with noncontiguous copy DNA (cDNA) portions, thus indicating the presence of a heterozygous gene deletion. The deletion removes a genomic region containing at least codons 1147 through 1854 and corre-ON WILLEBRAND factor (vWF) is a nonenzymatic
ON WILLEBRAND factor (vWF) is a nonenzymatic V glycoprotein active in primary hemostasis'; it plays a role in platelet adhesion to damaged vascular and in stabilizing the hemostatic plug. In addition, vWF stabilizes factor VI11 (FVIII) in plasma.536 The isolation of the cDNA for vWF7-" and the direct amino acid sequence analysis" have improved the understanding of the structure and properties of this von Willebrand disease (vWD) is a frequent and very heterogeneous bleeding disorder with either a quantitative deficiency or a qualitative abnormality of VWF.'~.' ' Several restriction fragment length polymorphisms (RFLPs)'~-*' have been detected in the vWF gene, and the haplotype analysis of vWD patients suggests that many independent mutations are pre~ent.'"'~ Additional nonfunctional mutations were found in the cDNA sequence."
Some of these mutations, deleterious or without phenotypic significance, could be de novo. The frequency of new mutations is relevant for genetic counseling purposes. In addition, a comparison with other genes in humans could give relevant information about different mutation rates affecting various portions of the human genome. 27 The analysis of gene defects is complicated by the presence of a partial pseudogene on chromosome 22." We sublocalized this homologous sequence to 22 q11.22-qll.23.
Gene deletions have been found associated with severe recessive vWD with antibodies but alterations causing the more frequent dominant types have not been described. We report a heterozygous gene alteration occurring de novo and associated with a variant of the dominant type I1 vWD.
MATERIALS AND METHODS
Blood samples were collected by standard procedures from normal and affected subjects who consented to be studied. The experiments were performed under standard regulations and those involving recombinant DNA were performed according to the accepted safety guidelines. Propositus: 23 years old, no bleeding history in his family, a long history'of nose bleeding (at least 100) from the first year of life, two tonsillar bleeding episodes, and many hospitalization periods due to severe bleeding.
Cell DNA was isolated by phenolchloroform extraction3' or by the perchlorate method." Six to 10 pg of DNA were digested with TaqI, BglII, EcoRI, BamHI, S a d , and XbaI restriction endonucleases under conditions recommended by
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Southern blot hybridizations.
sponding to the D3-A3 homologous protein domains. The extent of the vWF pseudogene on chromosome 22 is roughly similar to that of the deleted area. However, the pseudogenic nature of the deletion is excluded by the mapping of bands with reduced intensity in the patient to the true vWF gene. The vWF antigen levels are one fourth of normal and ristocetin cofactor activity is severely impaired. The reduction of high molecular weight multimers in plasma and platelets and the altered triplet morphology are compatible with the presence of a dominant variant of type II von Willebrand disease. 0 1990 by The American Society of Hematology.
the suppliers (Boehringer, Mannheim, FRG; New England Biolabs, Beverly, MA). Southern blotting was performed as previously described."
The full-length cDNA detects several overlapping bands and was not usually used; partial cDNAs were used as probes (Fig 1) Filter hybridization (50% formamide and 10% dextran sulphate at 42OC) and washing was performed according to the Gene Screen Plus transfer membrane method (New England Nuclear).
Coagulation and immunologic assays. The bleeding time and the FVIII procoagulant activity (V1II:C) were determined as previously de~cribed.'~ von Willebrand factor antigen (vWFAg) was measured by Laurell's te~hnique'~ using a specific rabbit antibody (Istituto Behring, Scoppito, Italy). Ristocetin cofactor was studied by the method of MacFarlane et a13' as modified by Casonato et using formalin fixed platelets. Multimeric analysis of vWF was performed using sodium dodecyl sulfate (SDS) agarose (1.8%, 2.3%) electrophoresis in a discontinuous bufler system. The vWF multimen were demonstrated by autoradiography after reaction with ':'l-labcled immunopurified anti-vWF antibody." hutoradiographs of the electrophoretic runs were scanned with an Ultroscanlaser Densitometer LKR (Pharmacia. Uppsala. Sweden).
RESULTS
Detection and characterization of the gene alteration. DNA was hybridized with partial cDNA probes spanning the complete factor sequence. including the antigen I I (Fig   1 ) .
In one patient an additional 13-kb fragment was detected (Table 1 ) and the ratios between corresponding bands in father and propositus, both homozygous for the 9.6-kb RFLP." were calculated. The values obtained for the 6.8-and 3.2-kb &/I1
bands clearly indicate a reduction in intensity by half. The ratios observed for the 2.7-and 2.3-kb bands, although lower than those of the 6.8-and 3.2-kb bands. are higher than the values calculated for normal This altered pattern is not present in the normal parents or in 25 unrelated affected subjects and 50 normal controls. The intragenic locali7ation of the possible alteration was studied with several probes obtained by restriction of full-length and partial cDNAs (see Fig I and Materials and Methods).
The additional 13-kb band and the 6.8-. 2.7-. and 2.3-kb bands with reduced intensity were detected by the small probe a / . a subfragment of probe a.
The 3.2-and 2.7-kb bands were detected when hybridized with probe a2 contiguous and 5' to probe a / . In addition. probe a2 recognizes a large IS-kb band with normal intensity. The 15-and 3.2-kb bands are also detected (not shown) by probe hl. partially overlapping with probe a2. The analysis was extended in the 5' direction with probe h2. This probe. in addition to normal bands. recognizes the 13-kb additional fragment and a 7.2-kb band with reduced intensity (Fig 2) .
As expectcd. the 13-kb additional band and the 3.2-and 7.2-kb bands with reduced intensity are detected (Fig 2) by probe h. which contains a large portion of a2 and the complete hl and h2 probes (Fig I ) 2 (probes a and b) and Fig 4 (probe a 1 1 3.2-and 7.2-kb bands is confirmed by densitometric scanning in the lanes of the patient and normal control (Table I , probe b). Probe b detects a faint 6.9-kb band, recognized also with reduced intensity by probe b l . The abnormal pattern was evident with several restriction enzymes, as follows. In BamHI digests of the patient's DNA (Fig 3A and B) , an additional band, 4.2 kb in size, is recognized as in BglII digests by the large probes a and b and their noncontiguous fragments a1 and b2. Bands with reduced intensity 3.4 and 9 kb in size are dctected by probes a. a l , and a2. respectively. In vWF gene BamHl restriction enzyme produces several comigrating bands approximately 9 kb in size, which complicate the analysis. The normal 3' portion of the gene recognized by probe a3. the most 3' cDNA fragment, is reported in Fig 3B .
In TaqI digests of the patient's DNA hybridized with probe al (Fig 4) , a 2.2-kb band with reduced intensity was detected. This reduction was also confirmed by densitometric scanning ( Table 1 , probe a l ) . In the TaqI pattern an additional band is not evident.
In the process of localizing two new Tag1 RFLPs,'* we hybridized DNA from a subject affected by a homozygous complete deletion of vWF gene and studied the inheritance of polymorphic TaqI fragment^.'^ These experiments enabled us to distinguish between genic (G) and pseudogenic (J.)
Taql bands recognized by probe a l , as reported in Analysis of von Willebrand factor in plasma and in platelets. The presence and activity of vWF was studied in the plasma of the family members (Table 2) . vWF antigen is present in reduced quantity in the propositus and normal in his parents and brother. The severe reduction of ristocetin cofactor activity, not proportional to the antigen level, indicates a marked functional deficiency in accordance with the clinical findings. The ristocetin-induced platelet aggregation was also severely reduced (data not shown). A reduction of the high molecular weight forms of multimers is evident particularly in the platelets (Fig 6, A through C ). An abnormal morphology of triplets was also observed and confirmed in longer gels with 2.3% agarose (Fig 7A and B) . The slow migrating band of the triplet is not detectable and a -- (Fig 6A, lane c) . 
DISCUSSION
An abnormal restriction pattern of the vWF gene was found in the DNA from a vWD patient hybridized with several cDNA probes. The fact that all bands are present, although some with reduced intensity, suggests a heterozygous lesion. The finding of abnormal patterns with several restriction enzymes excludes the presence of a point mutation and indicates that an extensive deletion has occurred in this gene. Since several bands are affected by the lesion, an insertional event, as described for hemophilia is not likely.
The additional fragments, likely to have been produced by the fusion of the 3' and 5' truncated boundaries of the lesion, are recognized by probes b2 and a1 and not by fragments a2 and b l . Because probes 62 and a1 correspond to codons 7 15 through 1147 and 1854 through 2005, respectively, the genomic region containing codons 1147 through 1854 is very likely to be absent in the altered gene (Fig 1) . Moreover, probe b2 detects several bands in the different digests with normal intensity and only one with reduced intensity, suggesting that the 5' boundary of the gene deletion is recognized by the 3' portion of this probe. The protein portion presumably removed by the gene deletion spans from the D3 to the A3 homologous domains" containing putative binding sites for G P l b, heparin, and ~o l l a g e n . '~ Since only small portions of the structure of the vWF gene, which is very large and rich in exons, have been des~ribed,2'.~'-~~ it is difficult to localize precisely the altered sites and the extent of the gene lesion. The deletion is at least 25 kb in size, as inferred by the bands with reduced intensity observed in BglII digesis, the most informative r.e. we used to characterize this lesion.
The analysis is complicated by the presence of a pseudogene on chromosome 22; the boundaries of the gene lesion are roughly similar to those of the p~e u d o g e n e .~~ Because genic and pseudogenic bands cannot be distinguished even in highly stringent washing conditions, it is important to exclude the possibility that the heterozygous lesion is located completely in the pseudogene.
Two independent pieces of experimental evidence indicate the true genic nature of the deletion. (1) In the genic region we mapped a 2.2-kb TaqI band, recognized with reduced intensity by probe a1 (Fig 4 and The presence of the altered vWF gene pattern in the propositus and not in his parents or in 153 control genes suggest that a de novo mutation is present in this subject. The normal inheritance of highly informative RFLPs, such as 3' HVR (heterozygosity greater than 90%) excludes nonpaternity. The cloning of very large genomic fragments of the propositus, including the lesion boundaries and the informative polymorphic alleles (Fig 5) , located in the 3' portion of vWF gene, could establish the parental inheritance of the pathologic gene.
The possibility of a high mutation rate of vWF gene, suggested by the many RFLPs, silent mutations, and the heterogeneity of vWD, predicts that de novo mutations the very reduced ristocetin cofactor activity (3%) suggest that the abnormal protein very likely interacts in the multimerimtion with the normal counterpart gene product. giving rise to a dominant phenotype. The additional presence in the family of an undetected altered gene producing a silent phenotype in one parent and possibly in the brother, expressed in the double heterozygous condition in the propositus. is not likely.
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The use of an antiproteolytic mixture in plasma does not change the multimeric pattern, excluding the possibility that increased proteolysis of the altered molecules is present!* The multimeric pattern does not seem to be superimposable on others previously described and can be defined as a variant of the dominant type 11.
This deletion, which is the first as we know of to be associated with the dominant form of vWD, could be a good model for the investigation of dominant human gene alterations.
